R + Cagrilintide Blend

This powerful peptide blend combines R and Cagrilintide, two compounds under investigation for their potential roles in advanced metabolic support and appetite regulation. R is a novel triple agonist that targets GLP-1, GIP, and glucagon receptors, showing promise in early studies for supporting weight management and energy balance. Cagrilintide is a long-acting amylin analog studied for its ability to promote satiety and delay gastric emptying. Together, these peptides may offer synergistic support for clinicians developing comprehensive protocols focused on appetite control, fat loss, and long-term metabolic health.